Galapagos NV
F:GXEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Galapagos NV
F:GXEA
|
BE |
|
Banco Santander SA
NYSE:SAN
|
ES |
|
T
|
Tenet Healthcare Corp
XMUN:THC1
|
US |
|
Atlassian Corporation PLC
NASDAQ:TEAM
|
UK |
|
C
|
Capital One Financial Corp
SWB:CFX
|
US |
|
S
|
Sinopharm Group Co Ltd
XBER:X2S
|
CN |
|
Abb Ltd
STO:ABB
|
CH |
|
Papa John's International Inc
NASDAQ:PZZA
|
US |
|
C
|
Compagnie Financiere Richemont SA
DUS:RIT1
|
CH |
|
Heineken Holding NV
LSE:0NBD
|
NL |
|
F
|
First Graphene Ltd
OTC:FGPHF
|
AU |
|
B
|
BlackRock TCP Capital Corp
F:8TC
|
US |
Wall St Price Targets
GXEA Price Targets Summary
Galapagos NV
According to Wall Street analysts, the average 1-year price target for
GXEA is 29.67 EUR with a low forecast of 18.88 EUR and a high forecast of 46.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GXEA's stock price target?
Price Target
29.67
EUR
According to Wall Street analysts, the average 1-year price target for
GXEA is 29.67 EUR with a low forecast of 18.88 EUR and a high forecast of 46.27 EUR.
What is the Revenue forecast for Galapagos NV?
Projected CAGR
-44%
Over the last 14 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 8 years is -44%.